Ewes were treated with exogenous follicle-stimulating hormone (FSH) and oestrus was synchronized using either a dual prostaglandin F-2\g=a\ (PGF-2\g=a\)injection regimen or pessaries impregnated with medroxy progesterone acetate (MAP). Natural cycling ewes served as controls. After oestrus or AI (Day 0), corpora lutea (CL) were enucleated surgically from the left and right ovaries on Days 3 and 6, respectively. The incidence of premature luteolysis was related (P < 0\m=.\05) to PGF-2\g=a\treatment and occurred in 7 of 8 ewes compared with 0 of 4 controls and 1 of 8 MAP-exposed females. Sheep with regressing CL had lower circulating and intraluteal progesterone concentrations and fewer total and small dissociated luteal cells on Day 3 than gonadotrophin-treated counterparts with normal CL. Progesterone concentration in the serum and luteal tissue was higher (P < 0\m=.\05) in gonadotrophin-treated ewes with normal CL than in the controls; but luteinizing hormone (LH) receptors/cell were not different on Days 3 and 6. There were no apparent differences in the temporal patterns of circulating oestradiol-17\g=b\, FSH and LH. High progesterone in gonadotrophin\x=req-\ treated ewes with normal CL coincided with an increase in total luteal mass and numbers of cells, which were primarily reflected in more small luteal cells than in control ewes. Gonadotrophin-treated ewes with regressing CL on Day 3 tended (P < 0\m=.\10) to have fewer small luteal cells and fewer (P < 0\m=.\05)low-affinity PGF-2\g=a\ binding sites than sheep with normal CL. By Day 6, luteal integrity and cell viability was absent in ewes with prematurely regressed CL. These data demonstrate that (i) the incidence of premature luteal regression is highly correlated with the use of PGF-2\g=a\;(ii) this abnormal luteal tissue is functionally competent for 2\p=n-\3 days after ovulation, but deteriorates rapidly thereafter and (iii) luteal-dysfunctioning ewes experience a reduction in numbers of small luteal cells without a significant change in luteal mass by Day 3 and, overall, have fewer low-affinity PGF-2\g=a\ binding sites.
Introduction
Premature demise of the corpus luteum (CL) after exogenous hormone stimulation is a poorly understood cause of embryo recovery failure in goats and sheep (Armstrong et ai, 1982 (Armstrong et ai, , 1983a Stubbing et ai, 1986; Schiewe et ai, 1990) . Luteal dysfunction in these species generally is characterized by a transient rise and fall in circulating progesterone concentrations within 4 days of ovulation (Armstrong et ai, 1982; Stubbing et ai, 1986; Southee et ai, 1988a) . It remains unclear whether prematurely regressing CL have an inherently short lifespan caused by inadequate preovulatory follicular development, premature luteolysin release or hypersensitivity to luteolysis due to reduced luteotrophin stimulation.
Ovine CL consist of large and small steroidogenic cells which have been described morphometrically (Rodgers et ai, 1984; Farin et ai, 1986) and biochemically (Fitz et ai, 1982; Hoyer & Niswender, 1985; Balapure et ai, 1989a) . Large and small luteal cells are believed to develop from follicular granulosa and theca interna cells, respectively (McClellan et ai, 1975; O'Shea et ai, 1980 ). An increase in luteal weight throughout the oestrous cycle of naturally cycling ewes is char¬ acterized by hyperplasia of small luteal cells and hypertrophy of large cells (Farin et ai, 1986 ). It appears that mean cell diameter and steroidogenesis stimulated by luteinizing hormone (LH) in small luteal cells are increased in cyclic ewes after superovulation (Hild-Petito et ai, 1987) . Small luteal cells contain most of the LH receptors (Fitz et ai, 1982) and have low-affinity binding sites for prostaglandin F-2a (PGF-2a) (Balapure et ai, 1989a) . Although LH binding to small luteal cells stimulates adenylate cyclase activity and increases steroidogenesis (Fitz et ai, 1982; Rodgers et ai, 1983; Hoyer & Niswender et ai, 1985; Harrison et ai, 1987) , the functional significance of low-affinity PGF-2a receptors is unclear. These sites may play a complementary role in luteolysis to high-affinity PGF-2a binding sites found on large luteal cells (Fitz et ai, 1982; Balapure et ai, 1989a) by binding excess PGF-2a released by the uterus during the onset of luteal regression (McCracken et ai, 1984) .
This study characterized premature luteal regression (PLR) in gonadotrophin-treated ewes by examining periovulatory endocrine patterns and luteal tissue function during the early luteal phase. We were particularly interested in determining whether the type of oestrus synchronization method used with ovulation induction contributed to abnormal luteal integrity. This was studied by relat¬ ing circulating concentrations of steroids and gonadotrophins, LH and PGF-2ot luteal cell receptor populations, luteal cell morphometrics and steroidogenesis to the occurrence of luteal dysfunction in oestrus-synchronized, superovulated sheep.
Materials and Methods
Animals and facilities. Western crossbred, multiparous, white-faced ewes (2-5 years of age), Dorset breeding rams and a vasectomized Dorset teaser ram were housed in outdoor, partially sheltered pens (6 25 m). All sheep were fed a hay-pelleted ration and lucerne roughage twice a day (07:00 and 15:00 h) and provided free access to water. Indoor box stalls (2-5 2-5 m) were used for isolating animals as needed.
Oestrus synchronization and ovulation induction. Sixteen females were either given a 6a-methyl-17aacetoxyprogesterone-pessary (MAP, 60 mg Depo-provera®: Upjohn Co., Kalamazoo, MÍ, USA; 12-day insertion interval; = 8) or given PGF-2a (Lutalyse®: Upjohn Co., 10 mg, i.m., 10 days apart; = 8) oestrus synchronization treatment as described by Schiewe et al. (1990) . Each female was given follicle-stimulating hormone pituitary extract (FSH-P) (Schering Veterinary Supplies, Kenilworth, NJ, USA) twice a day for 3 days (5, 4, 4, 3, 3 and 2 mg, respect¬ ively; i.m.) beginning 36 h before MAP removal or before the second PGF-2a injection. Ewes were placed with one of 4 brisket-painted Dorset rams 36 h after MAP removal or PGF-2a injection for natural mating and artificially in¬ seminated 12 h later. Four naturally cycling ewes, not treated with hormones, mated by a vasectomized ram served as controls. Oestrous behaviour was monitored in all ewes for at least 30 min twice a day (07:00 and 18:00 h) by checking for mounting activity or painted wool on the female's rump. Enucleation of luteal material and embryo collection. A laparoscopie examination was performed on Day 0,48-52 h after MAP removal or PGF-2a (near the expected time of ovulation) to document ovarian activity and to perform insemination in ulero (Schiewe et al, 1990) , in addition to natural mating. Control ewes, which had a prerequisite of 1 ovulation per ovary, were subjected to laparoscopy and a sham-AI 24 h after the onset of a natural oestrus (also designated Day 0). On Days 3 and 6, each ewe was anaesthetized and subjected to laparotomy (Schiewe et al, 1990) to remove all luteal tissue from the left and right ovary, respectively. Enucleation sites were closed with suture. Enucleated CL from each donor were placed together in sterile Hank's Balanced Salt Solution (HBSS, Hanks & Wallace, 1949) and stored at 4°C until prepared further for hormone receptor analysis. On Day 6, each uterine horn was exteriorized and flushed for embryos and ova (Schiewe et al, 1990) .
Luteal tissue preparation. Within 1-3 h of removal from the ovary, the CL were weighed with an analytical balance (Mettler AE100, Fisher Co., Springfield, NJ, USA) using a weight extrapolation method. Each CL was sliced into 0-5-mm sections using a Stadie-Riggs hand microtome (Thomas Scientific, Swedesboro, NJ, USA) and divided into 3 portions for separate analyses of LH and PGF-2a receptors and progesterone concentration. Tissue designated for LH receptor and progesterone concentration analysis was placed in 1-3-ml transport storage tubes (Fisher Co.), frozen directly in liquid N2 vapour and stored in liquid N2. The remaining luteal tissue, designated for PGF-2a receptor analysis, was weighed and then processed to prepare suspensions of isolated cells (Balapure et al, 1989b) . A suspension of single cells was prepared from the 0-5-mm slices by dissociating tissue in Ca2 + -and Mg2 + -free HBSS containing 2000 U collagenase (Worthington Biochemical Corp., Halls-Mills, Freehold, NJ, USA)/g tissue per flask, 01% bovine serum albumin (BSA, Fraction V, Sigma Chemical Co., St Louis, MO, USA) and 0-2% deoxyribonuclease (Sigma Chemical Co.). Luteal suspensions from Day-3 and Day-6 CL were incubated in a metabolic shaker bath at 37°C for 30 and 60 min, respectively. Dissociated cells were washed twice in tissue culture medium 199 (TCM 199, Morton, 1970) using refrigerated (4°C) centrifugation at 3000 g for 10 min to eliminate residual collage¬ nase. The final cellular pellet was resuspended in TCM 199 containing 0-3% BSA ( 1 ml/25 mg tissue). The preparation was stored overnight (4°C) and then frozen within 12 h of processing. The number of viable cells produced in each cell suspension preparation was counted (expressed on a basis of 500 mg luteal tissue) using a trypan blue stain and standard haemocytometer method immediately before freezing. The proportion of small ( 10-20 µ in diameter) and large (>20 µ in diameter) luteal cells in the tissue suspensions were assessed based on characteristic cellular differ¬ ences determined by others (Rodgers & O'Shea, 1982; Farin et al, 1986; Hild-Petito et al, 1987) . Although some cells may have been damaged during dissociation (particularly large cells, which are more fragile; Braden et al, 1988) , the procedures used for tissue dissociations and estimating numbers of cells were applied consistently throughout the project. Aliquants of cells were placed into cryovials in 0-5-ml TCM 199 and then 0-5 ml of 15% dimethyl sulphoxide (DMSO)-TCM 199 solution was added (at 4°C) and allowed to equilibrate for 10 min. Luteal cells were frozen in a programmable freezing unit by cooling at 4°C/min to -38°C and then 10°C/min to -I00°C before storage in liquid N2.
Blood sampling and radioimmunoassays. Blood samples (10 ml) were obtained by jugular venepuncture from all ewes beginning 1 day before gonadotrophin treatment or at the onset of detected oestrus for controls. Daily blood sampling (between 07:00 and 09:00 h) continued for 9-13 consecutive days. To characterize preovulatory oestradiol-17ß, FSH and LH dynamics in oestrus-synchronized animals, frequent blood samples were collected near the time of the anticipated preovulatory LH surge. To accommodate frequent blood sampling, ewes were moved from the outdoor pens to indoor-isolation stalls at the time of pessary removal or the PGF-2a injection. An indwelling catheter with an obturator (Becton-Dickinson, Rutherford, NJ, USA) to prevent clotting was inserted into a jugular vein. Beginning 12 h after pessary removal or PGF-2a injection, blood samples (5 ml/sample) were collected at intervals of 2 h for 24 h. All blood samples were processed for serum collection and storage (Schiewe et al, 1990 ) and serum oestradiol-17ß, FSH, LH and progesterone concentrations were determined using specific radioimmunoassay (RIA) procedures. Because a previous study had detected no differences in oestradiol-17ß concentrations in superovulated sheep with normal or abnormal luteal phases (Schiewe et al, 1990) , this hormone was measured only during the 24 h serial bleeding window to characterize the preovulatory oestradiol surge.
Steroid concentrations were determined in unextracted sera using commercially available [125I]double-antibody RIA kits (Radioassays Systems Inc., Carson, CA, USA) as detailed and validated for sheep (Schiewe et al, 1990 ). The minimum detectable oestradiol-17ß concentration (i.e. assay sensitivity) was 3-5 pg/ml based on that at which 95% maximum binding occurrred (ED95); 94-3 pg oestradiol-17ß/ml was needed to cause 50% binding inhibition (ED50). The assay sensitivity for progesterone was 0-1 ng/ml and the ED50 was 4-2 ng/ml. Serum LH and FSH were analysed by validated homologous double-antibody RIAs (Niswender et al, 1969; Brown et al, 1987) . Purified ovine FSH (LER-1976-A2) and LH (LER-I374-A) were used as the labelled ligands and NIH-LH-S18 and NIH-FSH-S8 as the standards. Duplicate aliquants of serum (100 µ ) or standards (0-03^l-0 ng LH/tube; 1 -6-200 ng FSH/tube, respectively) were incubated at 4°C with first antibody for 48 h and then with labelled hormone for 24 h. The second antibody was added 24 h after addition of labelled hormone (final volume = 500 µ ) and incubated for an additional 3 days before 1 ml of cold PBS was added and the antibody bound hormone was separated from free hormone by centrifugation (2500 g for 30 min). The ED50 values were 13 and 0-4ng/tube, and assay sensitivities were 10-9 and 0-5 ng/ml for 100 µ serum for the LH and FSH assays, respectively. Intra-and interassay variability for all assays was < 10%.
Progesterone content of luteal tissue. Progesterone content of luteal tissue was determined using the [125I]doubleantibody RIA procedure described for serum (Schiewe et al, 1990) . Wet weight of blot-dried tissue slices was determined using an analytical balance immediately before homogenization with a Polytron at medium speed using three 3-s pulses. To extract progesterone, homogenates were placed in 95% ethanol for 24 h. The homogenate was then pelleted by centrifugation (2500g for 10min) and separated from the supernatant, which was maintained at -20°C. Before subsequent determination of progesterone content, a dried aliquant of the organic phase was reconstituted in assay buffer.
LH receptor and PGF-2a receptor analysis. LH receptors were assessed using a modification of the procedure described by Diekman et al (1978) . The number of receptors for LH was determined using Scatchard analysis of saturation curves. Thawed tissue slices were homogenized as described above and suspended in 25mM Tris-HCl (pH 7-35) buffer containing lmM-CaCl2, lmM-NaN3 and 01% gelatin (1 ml/100 mg wet weight tissue equivalents). Duplicate aliquants (100 µ ) of luteal tissue homogenates (2 mg tissue weight) were incubated in Tris buffer with [I25I]labelled human chorionic gonadotrophin (hCG) (9-5 Ci/mmol; 100 µ ) ranging from 10 000 to 21 106 c.p.m. in a final volume of 500 µ to determine total binding. Parallel incubations of tubes containing nonradioactive hCG (1 µg in 100 µ HBSS; Sigma Chemical Co.) was used to determine the nonspecific binding. Samples were incubated in a metabolic shaker bath at 25°C for 16 h. After incubation, 3 ml of Tris buffer was added to all tubes containing tissue homogenates, the tubes were centrifuged at 7000 g (4°C) for 15 min and the supernatant was decanted. The radio¬ activity of each pellet was measured in a TM Analytic gamma counter having a [125I]detection efficiency of 82%. The LH receptor dissociation constant (Kd) was 5-54 + 213 10" ' ' M.
Prostaglandin F-2a receptor analyses were performed with thawed, luteal cell preparations (Balapure et al, 1989a, b) . Duplicate aliquants containing 50 000 large luteal cells (100 µ ) were incubated with 50nCi [3H]PGF-2a (195 Ci/mmol; 100 µ ) and one of 15 unlabelled PGF-2a buffer concentrations (0 to 16µ ) in a total volume of 210 µ HBSS-BSA buffer (pH 5-75) at 30°C for 45 min in a metabolic shaker bath. Ice-cold buffer (pH 7-35) containing 25mM Tris, lmM-CaCl2 and 01% BSA (Tris-Ca-BSA) was added (1-5 ml) to terminate incubation before applying the incubates to glass microfibre filters on a Yeda filtration manifold. The filters were washed twice with 1-5 ml of Tris-Ca-BSA buffer, placed in vials containing 10 ml scintillation fluid and equilibrated for~16 h at 4°C. Bound radioactivity was determined using a Tracor Mark III liquid scintillation, beta counter having a [3H]detection efficiency of 44%. Binding data were converted to Scatchard plots using ligand (Munson 8c Rodbard, 1980) . The number of high-and low-affinity PGF-2a receptors was quantitated by Scatchard analysis (binding affinity: Kd = 1209 + 1-20 and Kd = 870 ± 160 µ , respectively). Statistical analysis. A completely randomized design with an a priori arrangement of treatments was used to assess the periovulatory hormonal patterns and luteal characteristics of ewes synchronized into oestrus using MAP pessaries or PGF-2a. Analysis of variance (anova) with a general linear model format was used to assess statistical variations in ovulation rate, luteal weight, luteal cell types, receptor populations and progesterone content of luteal cells. These analyses were facilitated by using a computerized software package (systat: Wilkinson, 1987) . Differences among treatments were determined using Tukey's H.S.D. procedure (Snedecor & Cochran, 1980) . Pooled data involving the evaluation of ewes with normal luteal function versus those experiencing PLR were analysed using an independent Student's t test (Snedecor & Cochran, 1980) . Temporal profiles and differences in hormone concentrations over time were evaluated using a 2-way anova, repeated measures program. A hormonal surge was characterized as a profile in which the hormone concentration increased more than 3 standard deviations above basal concentrations. Results are expressed as means ± standard error of the mean (s.e.m.).
Results
Ovulation induction, luteal function and embryo recovery Superovulated ewes had more (P < 001) CL than did spontaneously ovulating control ewes (11-0 + 21 vs. 20 + 00CL). Mean luteal weight was greater (P < 005) on Day 3 in super¬ ovulated (1-0 ± 0-2 g) than in control ewes (0-3 + 0-1 g). Two types of CL were observed: (i) 'normal CL', which on Days 3 and 6 were bright red and prominently raised above the ovarian surface and (ii) 'prematurely regressing CL', which were pale and pink to white. The differences in gross coloration between CL types were usually evident by Day 3. By Day 6, regressing CL lacked any distinct vascularity and were white (i.e. appearing as corpora albicans).
The incidence of PLR was related to treatment and occurred in none of the controls, 1 of 8 MAP-synchronized females and 7 of 8 ewes treated within PGF-2a. Because a higher (P < 005) proportion of ewes treated with PGF-2a experienced early luteal regression, the mean total mass of luteal tissue/ovary on Day 6 (0-5 + 01 g) was less (P < 005) than in the MAP-synchronized group (2-2 +0-5 g).
On Day 3, CL undergoing premature luteolysis were no different in average weight from normal-appearing CL (Table 1) . By Day 6, however, ewes with normal CL had a 5-4-times greater (P < 001) mean luteal mass than PLR ewes. Mean CL weight was similar among groups with normal-appearing CL ( Table 1) . Regardless of treatment, there was a highly positive correlation between number of CL and CL weight on Day 3 (r = 0-88, < 0001) which was not evident on Day 6 (r = 0-30, > 010) because of rapidly declining CL function in half the hormone-treated ewes. Embryos or ova were recovered from all donors with normal-appearing luteal tissue (mean 7-7 + 2-2 embryos/ewe); none was recovered from donors experiencing PLR.
Temporal endocrine patterns
Preovulatory oestradiol-17ß surges were detected in 14 of 16 hormone-stimulated ewes, and there was no treatment effect (P > 005) on the magnitude or duration of the preovulatory oestradiol-17ß surge (Fig. 1 ). Generally, serum oestradiol-17ß concentrations increased more than 8-10-fold from basal concentrations (4-6 pg/ml) to a peak of 59-3 ± 10-9 pg/ml, which occurred by 20-36 h (25-4 ± 1-5 h; surge duration of 6-12 h) after MAP removal or PGF-2a injection. After ovulation, mean serum LH profiles were similar (P > 010) in control and FSH-P-treated ewes (Fig. lb, d) . Likewise, there were no differences (P > 0-10) in peripheral FSH or LH concentrations or temporal patterns within oestrus synchronization treatments. Regardless of whether FSH-Ptreated ewes eventually produced normal or regressed CL, the FSH and LH patterns were similar (P > 010; Fig. ld , f)· Preovulatory FSH surges were detected in 13 of 16 hormone-treated ewes. Serum FSH patterns increased from a baseline of 50-100 ng/ml to a peak of 2370 + 14-4 ng/ml (range 180-330 ng/ml) which occurred 26-5 + 11 h after MAP removal or PGF-2a injection. Across treatment groups, a preovulatory surge of LH was detected in 11 of 16 ewes and was sustained for~6-1 Oh. Circulating LH increased from a baseline of 3-7ng/ml to a peak of 72-4 ± 4-2 ng/ml (range 60-85 ng/ml) which occurred 28-8 + 11 h after MAP removal or PGF-2ct injection. There was little fluctuation in circulating LH concentrations after ovulation (remaining < 10 ng/ml) and no difference (P > 010) among the control or oestrus synchronization treatment groups (Fig. lb, d, f ).
Compared with naturally cycling ewes, serum progesterone was detectable in FSH-P-treated ewes 48-72 h before controls. In sheep with normal CL, mean circulating progesterone concen¬ trations from Day 2 to Day 6 were higher (P < 005) than in controls with peak progesterone production (4-3 + 0-6ng/ml) being an average of 3 times greater (P < 005; Fig. la,c) . There was no apparent difference in the circulating progesterone pattern between MAP-and PGF-2o> synchronized ewes within normal or regressing CL groups. The most marked difference was in the postovulatory progesterone profile for control and normal luteal function ewes compared with sheep undergoing early luteolysis (Fig. la, c, e ). Although mean progesterone concentrations were higher (P < 005) on Day 2 in FSH-P-treated (0-9 ± 0-2 ng/ml) than in control ewes (0-2 ng/ml), progesterone concentration steadily declined thereafter in sheep experiencing PLR (Fig. le) . Mean circulating progesterone concentration in the latter ewes was not different (P > 010) from controls on Day 3, but was reduced (P < 005) by Day 4 to basal levels (^0-2 ng/ml). 
Control/sham
Normal CL Premature luteal regression 2-2 + 0-4" 5-1 ± 2-0" 7-2 ± 1-6" 4-2+ 1-5" 13-5 + 3-3"* 17-8 + 4-7a* 301 4-38 1 1-7* 9-25 ± 0-8" 12-3 + 0-4' 25-69 + 5-3b 301 + 6-7b 2-9 ± 1-0* 6-6 ± l-6al 9-6 ± 2-4a! ND ND ND abMean ( +s.e.m) column values with different superscripts differ (P < 005). * Excluding control ewes, a (-test comparison between ewes treated with follicle-stimulating hormone pituitary extract (normal CL vs. PLR) indicates differences (P < 005) in mean ( +s.e.m) column values. ND = not detected.
Day 0 = day of artificial insemination and onset of ovulation.
Luteal integrity
On Day 3, dissociates from control sheep and ewes with normal CL or PLR had similar numbers of large luteal cells (Table 2) , but FSH-P-treated ewes with normal CL had more (P < 005) small and total luteal cells than controls or sheep with early regressing CL. On Day 6, luteal cells were so atrophied in the PLR group that quantitating large versus small cells was impossible. More (P < 005) small and total luteal cells (a~3 -fold increase) were observed on Day 6 in the gonadotrophin-treated ewes with normal CL than in controls. For both groups, the number of large cells remained constant between Days 3 and 6, but the number of small cells increased (P < 0-05) by~1 -7 times.
FSH-P-treated ewes with normal CL had more progesterone/mg of luteal tissue than control sheep on Days 3 and 6 and females experiencing PLR on Day 6 (Table 3 ). It appeared that pro¬ gesterone secretion was compromised by~6 0 h after ovulation in ewes with short luteal phases. No differences (P > 005) were detected in numbers of LH receptors on Day 3 between normal and regressing CL groups (Table 3) , but, by Day 6, the LH receptor population was 4-5 times higher (P < 005) in controls and ewes with normal CL than in those with PLR. Evaluation of PGF-2a Bound 10"9 (mol/I) Fig. 3 . Representative Scatchard analysis plots for prostaglandin F-2a (PGF-2a) receptor bind¬ ing for (a) a control ewe and (b) a ewe treated with medroxyprogesterone acetate and folliclestimulating hormone pituitary extract and with normal corpora lutea on Day 6. The binding patterns revealed the presence of both high-affinity (almost vertical slope) and low-affinity (almost horizontal slope) binding sites.
receptors revealed no significant differences in the number of high-affinity receptors on Days 3 or 6, although there tended (P < 010) to be fewer on Day 3 in the PLR group than in ewes with normal CL. Numbers of low-affinity PGF-2a receptors were not different (P > 010) in controls and ewes with normal CL on Days 3 and 6 ( Table 3 ). In contrast, fewer (P < 005) low-affinity PGF-2a receptors were detected in sheep with regressing CL on Day 3 than in controls. Neither LH nor PGF-2ot receptor population affinities were influenced by exogenous hormone treatment, as demonstrated by the similarity of Scatchard analysis binding plots for representative naturally cycling or hormone-treated ewes (Figs 2 and 3, respectively ).
Discussion
Using FSH-P with either an MAP or a PGF-2a oestrus synchronization treatment produced mul¬ tiple ovulations in sheep similar to our other recent findings (Schiewe et al, 1990) . The present investigation affirmed that PGF-2a oestrus synchronization was associated with a high incidence of PLR in FSH-treated sheep. Additionally, we compared FSH-P, pregnant mares' serum gonado¬ trophin (PMSG) and human menopausal gonadotrophin and determined that the premature demise of multiple CL was not associated with a specific gonadotrophin used (Schiewe et al, 1990) . Luteal dysfunction was also observed in one of 5 natural cycling ewes given PGF-2a, but not in sheep pretreated with MAP pessaries (Schiewe et ai, 1990) . In agreement with our earlier investigation, no embryos were recovered from ewes with regressed CL. Luteal dysfunction has been observed frequently in goats treated with PMSG or PGF-2a (Armstrong et ai, 1983b; Stubbing et ai, 1986) . In our study, circulating progesterone profiles clearly indicated that premature CL demise in gonadotrophin-treated ewes occurred 2-3 days after ovulation, which was similar to endocrine results in hormone-treated goats (Armstrong et ai, 1983b) . Findings of early luteal regression were also similar to those observed in anoestrous ewes induced to ovulate with GnRH (McLeod et ai, 1982; McLeod & Haresign, 1984; Hunter et ai, 1988; Southee et ai, 1988a) or by ram exposure (Oldham & Martin, 1978; Oldham et ai, 1985; Pearce et ai, 1987) . Luteal development depends on major cellular transformations in the postovulatory follicle; therefore, the factors normally influencing follicular maturation (i.e. numbers of granulosa cells and gonadotrophin receptors) may contribute to luteal competence (Armstrong et ai, 1982) . Pre¬ ovulatory progesterone priming appears critical to normal luteal development in sheep, especially in previously acyclic ewes (McLeod & Haresign, 1984; Pearce et ai, 1985; Southee et ai, 1988a ). An intriguing, yet confounding, factor in our study was that ewes were under the influence of endogenous progesterone immediately before PGF-2a. Despite this 'priming' effect, a high incidence of PLR occurred. It is possible that a critical duration (i.e. days) of progesterone priming of follicular maturation was not achieved using the double PGF-2a injection, oestrus synchronization approach. Conversely, preovulatory MAP treatment may have allowed sufficient time for follicular cells to acquire the maturity needed for optimal luteinization and functional development (Armstrong et ai, 1982) . Progestogen priming before ovulation induction eliminates premature luteolysis in anoestrous ewes (McLeod & Haresign, 1984; Oldham et ai, 1985; Southee et ai, 1988a) . Interestingly, the common occurrence of premature luteolysis in PGF-2a-treated ewes could not be attributed to differences in temporal hormonal profiles during the periovulatory period. This suggests two possibilities. First, the similarity in preovulatory gonadotrophin and oestradiol-17ß profiles may indicate that folliculogenic events are not associated with premature CL demise. Alternatively, circulating hormones may be inadequate markers for these events or the blood sampling protocol used may not have been sufficiently rigorous to detect subtle endocrine differences between animal groups. The increased total luteal weight observed in gonadotrophin-treated ewes with normal CL, compared with controls, was due mostly to an increased population of small luteal cells. Corpora lutea from ewes undergoing premature luteolysis were already experiencing a sharp reduction in both large and small luteal cells by Day 3, but the primary loss was of the smaller cells. Although total luteal mass was greater in sheep with regressing CL than in controls, these CL did not produce more small luteal cells or progesterone (in circulation or in tissue). Since LH-stimulated progester¬ one production by small luteal cells increases significantly in ewes injected with PMSG (Hild-Petito et ai, 1987), it is likely that the increased serum progesterone concentrations and progesterone content/mg luteal tissue in gonadotrophin-treated sheep was due to more small cells and enhanced steroidogenesis. The improved steroidogenic potential of the small luteal cells, however, could not be attributed to increased LH binding, because the number of LH receptors/mg tissue was no different among groups. A recent study of short-lived CL in post-partum ewes (Braden et ai, 1989) has also determined that the reduced steroidogenic competence of luteal cells is not caused by changes in numbers of LH receptors. Therefore, the decline in progesterone production by Day 3 in gonadotrophin-treated ewes with regressing CL was probably due to a reduced steroidogenic popu¬ lation of small luteal cells and/or insensitivity to luteotrophic stimuli.
The rapid loss of luteal integrity during short luteal phases was similar to the normal demise of CL caused by increased pulsatile release of PGF-2a from the uterus (McCracken et ai, 1984) . The occurrence of PLR at~D ay 4 after the LH surge was consistent with the time when natural cyclic ewes are susceptible to exogenous prostaglandin-induced luteolysis (Acritopoulou & Haresign, 1980) . Several studies indicate that some factor of uterine origin (probably PGF-2a) is responsible for PLR (Lewis & Bolt, 1987; Copelin et ai, 1987; Southee et ai, 1988b) . It also could be due to increased sensitivity of the CL to tonic secretion of a luteolysin (Braden et ai, 1989 ). In the latter study, early luteolysis during the post-partum period could not be attributed to increased numbers of prostaglandin receptors or binding affinity to PGF-2ct by the large luteal cells. In the present study, we identified 2 types of PGF-2a binding sites (high and low affinity), which verified other recent reports (Balapure et ai, 1989a, b) . Differences in numbers of PGF-2a receptors and luteal cells were not detected between control and gonadotrophin-treated ewes producing normal luteal tissue, but ewes experiencing premature luteolysis had fewer low-affinity PGF-2a receptors (Day 3), which are the binding sites located predominantly on small luteal cells (Balapure et ai, 1989a) . A relationship may exist between the number of low-affinity PGF-2a receptors on small luteal cells and luteal competence. It is also possible that the low-affinity PGF-2ct binding site has a high affinity for some other eicosanoid, perhaps a luteotrophin such as PGE2 (Balapure et ai, 1989a) . In our study, the onset of premature luteal demise occurred when large luteal cells acquired highaffinity PGF-2a binding sites (Fitz et ai, 1982) . The tendency for fewer high-affinity receptors in sheep with abnormal CL may indicate increased occupancy of PGF-2a at the binding site. If so, the potential hypersensitivity of these CL to the luteolysin may have been masked by the PGF-2a receptor downregulation. It is interesting that dissociates from CL destined for early regression contained fewer small, but not large, cells. A preferential loss of small luteal cells during luteolysis was reported in morphometric analyses of ovine luteal slices (Braden et ai, 1988) and dissociates (Schwall et ai, 1986) . The reduced abundance of small cells during luteolysis as well as in CL destined for premature involution implies that the 2 processes may be related, and that the small cells (or their paucity) may play a role in both processes.
Although effective for inducing luteolysis and oestrus in ewes, the influence of PGF-2a on subsequent luteal development must be considered critically. Our data suggest that, under the conditions described, exogenous PGF-2a is contraindicated because of an increased incidence of PLR. Hypotheses that the cause of early luteolysis was associated with abnormal preovulatory endocrine events and/or inadequate follicular maturation were not substantiated by these or other recent results from our laboratory (Schiewe et ai, 1990) . The latter study determined that numbers of antral follicles and time of ovulation did not differ in gonadotrophin-treated ewes with normal or regressed CL. The cause of luteal dysfunction remains unknown. However, changes in the number of small luteal cells and low-affinity PGF-2a binding sites in the periovulatory period may be responsible for the transient normality of CL function. Additional studies are necessary to determine the influence of PGF-2a on development, maturation and transformation of follicular theca and granulosa cells to luteal cells. Our understanding of the cause of PLR may be improved if we can resolve how progestogen pretreatment inhibits the abnormal physiological changes associated with early luteolysis.
